Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Interaction Map Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 2101 to 2150 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
prefoldin subunit 6 (protein ke2). [source:swissprot;acc:o15212]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
912\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5480.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4982.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09996\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
preimplantation protein 3; likely ortholog of preimplantation protein 3. [source:refseq;acc:nm\_015387]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
844\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6934.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6276.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1048\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
presenilin 1 (ps-1) (s182 protein). [source:swissprot;acc:p49768]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
102\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3225.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2353.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.3705\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
presenilin 2 (ps-2) (stm-2) (e5-1) (ad3lp) (ad5). [source:swissprot;acc:p49810]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
98\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
presenilin enhancer 2; hematopoietic stem/progenitor cells protein mds033. [source:refseq;acc:nm\_172341]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3100\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
presenilin-like protein 1 (ec 3.4.99.-) (sppl2b protein). [source:swissprot;acc:q8tct7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2460\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4900.37\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4751.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03128\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
presenilin-like protein 2 (ec 3.4.99.-) (sppl2a protein). [source:swissprot;acc:q8tct8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2458\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
presenilins associated rhomboid-like protein. [source:refseq;acc:nm\_018622]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1347\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6640.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6153.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07921\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
presynaptic density protein 95 (psd-95) (discs, large homolog 4) (postsynaptic density-95). [source:swissprot;acc:p78352]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2086\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6159.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5835.44\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05552\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
presynaptic protein sap102 (synapse-associated protein 102) (neuroendocrine-dlg) (ne-dlg) (discs, large homolog 3). [source:swissprot;acc:q92796]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2087\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6159.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5835.45\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
presynaptic protein sap97 (synapse-associated protein 97) (discs, large homolog 1) (hdlg). [source:swissprot;acc:q12959]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2088\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6159.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5835.15\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
prip-interacting protein pipmt; prip-interacting protein with methyltransferase domain. [source:refseq;acc:nm\_024831]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2455\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6166.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5978.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03145\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
prkca-binding protein (protein kinase c-alpha binding protein) (protein interacting with c kinase 1). [source:swissprot;acc:q9nrd5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3143\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable atp-dependent 61 kda nucleolar rna helicase (dead-box protein 21). [source:swissprot;acc:q9ny93]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
335\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4129.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3494.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18181\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable atp-dependent helicase ddx35 (deah-box protein 35). [source:swissprot;acc:q9h5z1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2037\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7315.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05706\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable atp-dependent rna helicase ddx20 (dead-box protein 20) (dead- box protein dp 103) (component of gems 3) (gemin3). [source:swissprot;acc:q9uhi6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2003\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5344.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5047.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05894\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable atp-dependent rna helicase p54 (oncogene rck) (dead-box protein 6). [source:swissprot;acc:p26196]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
389\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable calcium-transporting atpase kiaa0703 (ec 3.6.3.8). [source:swissprot;acc:o75185]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
605\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6950.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6143.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1314\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable cation-transporting atpase 1 (ec 3.6.1.-). [source:swissprot;acc:q9nq11]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1191\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7174.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6599.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08704\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable dimethyladenosine transferase (ec 2.1.1.-) (s- adenosylmethionine-6-n',n'-adenosyl(rrna) dimethyltransferase) (18s rrna dimethylase). [source:swissprot;acc:q9unq2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1231\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5569.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5132.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08511\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable glutamyl-trna(gln) amidotransferase subunit b, mitochondrial precursor (ec 6.3.5.-) (glu-adt subunit b) (cytochrome oxidase assembly factor pet112 homolog). [source:swissprot;acc:o75879]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1954\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6245.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5888.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06073\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable leucyl-trna synthetase, mitochondrial precursor (ec 6.1.1.4) (leucine--trna ligase) (leurs). [source:swissprot;acc:q15031]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1067\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5917.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5417.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09243\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable ribosome biogenesis protein nep1 (c2f protein). [source:swissprot;acc:q92979]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
862\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4497.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4076.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10327\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable rrna processing protein ebp2 (ebna1 binding protein 2) (nucleolar protein p40). [source:swissprot;acc:q99848]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
444\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4322.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3758.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15011\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable serine protease htra3 precursor (ec 3.4.21.-). [source:swissprot;acc:p83110]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
373\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5926.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5066.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16955\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable serine protease htra4 precursor (ec 3.4.21.-). [source:swissprot;acc:p83105]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
372\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5926.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5067\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16956\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
probable serine/threonine-protein kinase kiaa0537 (ec 2.7.1.-). [source:swissprot;acc:o60285]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2729\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5351.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5333\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00349\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
programmed cell death 10; apoptosis-related protein 15. [source:refseq;acc:nm\_007217]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3052\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
programmed cell death protein 5 (tfar19 protein) (tf-1 cell apoptosis related gene-19 protein). [source:swissprot;acc:o14737]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
873\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5237.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4749.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1028\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
programmed cell death protein 6 (probable calcium-binding protein alg- 2). [source:swissprot;acc:o75340]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
439\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7192.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6252.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15039\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
programmed cell death protein 8, mitochondrial precursor (ec 1.-.-.-) (apoptosis-inducing factor). [source:swissprot;acc:o95831]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2696\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5154.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5176.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00436\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
prohibitin. [source:swissprot;acc:p35232]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
550\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6563.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5773.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13687\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proliferating cell nuclear antigen (pcna) (cyclin). [source:swissprot;acc:p12004]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1593\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5333.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4977.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07152\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proliferating-cell nucleolar antigen p120 (proliferation-associated nucleolar protein p120). [source:swissprot;acc:p46087]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
469\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4388.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3831.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14554\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proliferation-associated protein 2g4 (cell cycle protein p38-2g4 homolog) (hg4-1). [source:swissprot;acc:q9uq80]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1707\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6174.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5777.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06873\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proline oxidase, mitochondrial precursor (ec 1.5.3.-) (proline dehydrogenase). [source:swissprot;acc:o43272]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1086\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7119.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6520.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09187\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proline synthetase co-transcribed bacterial homolog protein. [source:swissprot;acc:o94903]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
435\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6022.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5233.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1507\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
prolyl 4-hydroxylase alpha-1 subunit precursor (ec 1.14.11.2) (4-ph alpha-1) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-1 subunit). [source:swissprot;acc:p13674]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2109\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7295.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6916.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05481\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
prolyl 4-hydroxylase alpha-2 subunit precursor (ec 1.14.11.2) (4-ph alpha-2) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-2 subunit). [source:swissprot;acc:o15460]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2112\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
propionyl-coa carboxylase beta chain, mitochondrial precursor (ec 6.4.1.3) (pccase beta subunit) (propanoyl-coa:carbon dioxide ligase beta subunit). [source:swissprot;acc:p05166]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
850\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6839.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6194.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10417\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proprotein convertase subtilisin/kexin type 5 precursor (ec 3.4.21.-) (proprotein convertase pc5) (subtilisin/kexin-like protease pc5) (convertase pc5) (pc6) (hpc6). [source:swissprot;acc:q92824]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
734\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11864\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13241.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1161\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
prostate tumor overexpressed gene 1; prostate tumor over expressed gene 1. [source:refseq;acc:nm\_017432]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3106\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protease inhibitor 15 preproprotein; 25 kda trypsin inhibitor. [source:refseq;acc:nm\_015886]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2966\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proteasome activator complex subunit 3 (proteasome activator 28-gamma subunit) (pa28gamma) (pa28g) (activator of multicatalytic protease subunit 3) (11s regulator complex gamma subunit) (reg-gamma) (ki nuclear autoantigen). [source:swissprot;acc:q12920]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2997\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proteasome subunit alpha type 1 (ec 3.4.25.1) (proteasome component c2) (macropain subunit c2) (multicatalytic endopeptidase complex subunit c2) (proteasome nu chain) (30 kda prosomal protein) (pros-30). [source:swissprot;acc:p25786]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1572\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6504.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6068.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07194\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proteasome subunit alpha type 2 (ec 3.4.25.1) (proteasome component c3) (macropain subunit c3) (multicatalytic endopeptidase complex subunit c3). [source:swissprot;acc:p25787]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1565\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6803.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6343.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07246\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proteasome subunit alpha type 3 (ec 3.4.25.1) (proteasome component c8) (macropain subunit c8) (multicatalytic endopeptidase complex subunit c8). [source:swissprot;acc:p25788]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1405\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6781.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6291.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07783\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proteasome subunit alpha type 4 (ec 3.4.25.1) (proteasome component c9) (macropain subunit c9) (multicatalytic endopeptidase complex subunit c9) (proteasome subunit l). [source:swissprot;acc:p25789]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1578\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6659.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6213.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0718\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proteasome subunit alpha type 5 (ec 3.4.25.1) (proteasome zeta chain) (macropain zeta chain) (multicatalytic endopeptidase complex zeta chain). [source:swissprot;acc:p28066]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
636\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6432.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5713.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12593\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proteasome subunit alpha type 6 (ec 3.4.25.1) (proteasome iota chain) (macropain iota chain) (multicatalytic endopeptidase complex iota chain) (27 kda prosomal protein) (pros-27) (p27k). [source:swissprot;acc:p34062]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1637\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6540.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6112.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07008\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/